Risk factors for the development and progression of dyslipidemia after heart transplantation

Transplantation

Volumn 73, Issue 8, 2002, Pages 1258-1264

  Akhlaghi, Fatemeh ^a,b   Jackson, Christopher H ^a,c   Parameshwar, Jayan ^a,b   Sharples, Linda D ^a,b,c   Trull, Andrew K ^a,b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; BUMETANIDE; CHOLESTEROL; CREATININE; CYCLOSPORIN A; DIURETIC AGENT; FUROSEMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOLAZONE; PREDNISOLONE; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE PREDISPOSITION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037181719     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200204270-00012     Document Type: Article

References (27)

1. Hyperlipidemia in solid organ transplantation
2. The registry of the international society for heart and lung transplantation: Seventeenth official report-2000
3. Atherosclerosis-an inflammatory disease
4. Cellular and molecular mechanisms in transplant arteriosclerosis
5. The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation
6. Unbound cyclosporine and allograft rejection after heart transplantation
7. Pathophysiology and treatment of lipid pertubation after cardiac transplantation
8. Secondary dyslipidaemia: Inadvertent effects of drugs in clinical practice
9. The effects of antihypertensive drugs on serum lipids and lipoproteins II. Non-diuretic drugs
10. Effects of antihypertensives on plasma lipids and lipoprotein metabolism
11. The effects of antihypertensive drugs on serum lipids and lipoproteins 1
12. De novo development of hypercholesterolemia and elevated high-density lipoprotein cholesterol: Apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation
13. Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients
14. Hyperlipidemia in liver transplant recipients: Prevalence and risk factors
15. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients
16. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients
17. Effects of tacrolimus on hyperlipididaemia after successful renal transplantation
18. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus
19. Diuretics and beta-blockers: Is there a risk for dyslipidemia?
20. Fluctuations in blood lipid levels during furosemide therapy: A randomized, double-blind, placebo-controlled crossover study
21. A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: The bumetanide and furosemide on lipid profile (BUFUL) clinical study report
22. Hyperosmolar non-ketotic diabetes mellitus associated with metolazone
23. Lipid abnormalities in end stage renal disease
24. The dyslipoproteinemias of diabetes
25. Premature cardiovascular disease in chronic renal failure
26. Increased Lipoproteins and fibrinogen in chronic renal allograft dysfunction
27. Drug treatment of lipid disorders